Garuda Therapeutics’ Launch and $72 Million Series A Financing

Martina Bellini North America Legal Chronicle
Tagged:

Goodwin Procter advised Garuda Therapeutics on the deal.Garuda Therapeutics announced its launch and $72 million Series A financing led by Aisling Capital, Northpond Ventures, and OrbiMed, and…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:
Martina Bellini

Author: Martina Bellini

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here